Mindray quickly restarted the IPO and has begun accepting Huatai United Securities listing counseling
February 23, 2018, public documents show that the Commission, Shenzhen Mindray Bio-Medical Electronics (hereinafter referred to as Mindray Medical) IPO application was terminated review February 13, 2018, we were divergent views on the next step in the listing of Mindray At the time of the conjecture, Mindray Medical quickly returned and re-started after more than 20 days. Some analysts said that this may still be the largest IPO of China's A-share medical care market value of the year.
Recently, Huatai United Securities Co., Ltd. (hereinafter referred to as Huatai United) hanged a document on the official website of Shenzhen Mindray Biomedical Electronics Co., Ltd. for initial public offering and listing counseling (hereinafter referred to as listing filing information), showing Mindray. The project accepted the listing counseling of Huatai United and filed with the Shenzhen Securities Regulatory Bureau on March 6.
Mindray Medical related people confirmed the above news, saying that the company has re-launched the listing, the sponsor institution is Huatai United, and the only one (this means that Huatai United will exclusively enjoy the counseling sponsorship fee for this China's largest medical device manufacturer to return to A) The last Mindray IPO was jointly coached by Huatai United and BOC International Securities, and finally entered the SME IPO audit waiting process in May 2017. The auditor is PricewaterhouseCoopers Zhongtian Certified Public Accountants (special general partnership).
Where is Mindray Medical going to be listed, "Listing Filing Information" only shows "Minray intends to issue initial public offerings and list on domestic stock exchanges", but there are reports that it is different from previous Mindray's IPO review waiting for small and medium-sized board. Mindray reported on the GEM of the GEM. For the statement on the GEM, Mindray Medical said it would not respond.
As a leading domestic medical device company, Mindray Bio is one of the wind vanes for the privatization of A shares in China. In March 2016, Mindray Biotech announced that it has completed a $3.3 billion privatization transaction and delisted from the NYSE. Since then, Mindray Bio’s “Back to A†program has been followed by the outside world.
For the re-listing of Mindray Medical, some industry insiders said that the CSRC will open an IPO green channel for the "unicorn" company in four industries of Biotechnology, cloud computing, artificial intelligence and high-end manufacturing. The relevant IPO green channel policy or landing after two sessions may accelerate the listing process of Mindray.
Second-Hand Rapier Loom,Air Jet Loom,Water Jet Loom,Electronic Jacquard Machine,Second-Hand Weaving Machine,Textile Machinery
Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejts.com